IKNA
Price
$1.42
Change
+$0.12 (+9.23%)
Updated
Jun 6 closing price
Capitalization
68.53M
59 days until earnings call
SYRE
Price
$16.97
Change
+$0.35 (+2.11%)
Updated
Jun 6 closing price
Capitalization
1.02B
52 days until earnings call
Interact to see
Advertisement

IKNA vs SYRE

Header iconIKNA vs SYRE Comparison
Open Charts IKNA vs SYREBanner chart's image
Ikena Oncology
Price$1.42
Change+$0.12 (+9.23%)
Volume$213.32K
Capitalization68.53M
Spyre Therapeutics
Price$16.97
Change+$0.35 (+2.11%)
Volume$309.21K
Capitalization1.02B
IKNA vs SYRE Comparison Chart
Loading...
IKNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IKNA vs. SYRE commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IKNA is a Hold and SYRE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (IKNA: $1.15 vs. SYRE: $15.08)
Brand notoriety: IKNA and SYRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IKNA: 150% vs. SYRE: 105%
Market capitalization -- IKNA: $68.53M vs. SYRE: $1.02B
IKNA [@Biotechnology] is valued at $68.53M. SYRE’s [@Biotechnology] market capitalization is $1.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $334.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IKNA’s FA Score shows that 1 FA rating(s) are green whileSYRE’s FA Score has 0 green FA rating(s).

  • IKNA’s FA Score: 1 green, 4 red.
  • SYRE’s FA Score: 0 green, 5 red.
According to our system of comparison, IKNA is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IKNA’s TA Score shows that 3 TA indicator(s) are bullish while SYRE’s TA Score has 4 bullish TA indicator(s).

  • IKNA’s TA Score: 3 bullish, 4 bearish.
  • SYRE’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, SYRE is a better buy in the short-term than IKNA.

Price Growth

IKNA (@Biotechnology) experienced а 0.00% price change this week, while SYRE (@Biotechnology) price change was +2.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

IKNA is expected to report earnings on Aug 07, 2025.

SYRE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYRE($1.02B) has a higher market cap than IKNA($68.5M). IKNA YTD gains are higher at: -29.878 vs. SYRE (-35.223). IKNA has higher annual earnings (EBITDA): -54.06M vs. SYRE (-208.57M). SYRE has more cash in the bank: 603M vs. IKNA (124M). SYRE has less debt than IKNA: SYRE (0) vs IKNA (7.52M). IKNA (0) and SYRE (0) have equivalent revenues.
IKNASYREIKNA / SYRE
Capitalization68.5M1.02B7%
EBITDA-54.06M-208.57M26%
Gain YTD-29.878-35.22385%
P/E RatioN/A1.68-
Revenue00-
Total Cash124M603M21%
Total Debt7.52M0-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IKNASYRE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 13 days ago
81%
Bearish Trend 13 days ago
88%
Momentum
ODDS (%)
Bearish Trend 13 days ago
83%
Bullish Trend 13 days ago
80%
MACD
ODDS (%)
Bullish Trend 13 days ago
78%
N/A
TrendWeek
ODDS (%)
Bullish Trend 13 days ago
80%
Bearish Trend 13 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 13 days ago
88%
Bullish Trend 13 days ago
83%
Advances
ODDS (%)
Bullish Trend 20 days ago
82%
Bullish Trend 29 days ago
84%
Declines
ODDS (%)
Bearish Trend about 1 month ago
88%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 13 days ago
86%
Bearish Trend 14 days ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IKNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

IKNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IKNA has been loosely correlated with VNDA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if IKNA jumps, then VNDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKNA
1D Price
Change %
IKNA100%
-2.13%
VNDA - IKNA
37%
Loosely correlated
-0.46%
TERN - IKNA
33%
Loosely correlated
+1.66%
LENZ - IKNA
30%
Poorly correlated
-2.35%
SYRE - IKNA
30%
Poorly correlated
+0.60%
SRPT - IKNA
30%
Poorly correlated
-2.92%
More

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with BEAM. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
+0.60%
BEAM - SYRE
56%
Loosely correlated
-0.88%
APGE - SYRE
53%
Loosely correlated
-1.30%
IMNM - SYRE
52%
Loosely correlated
+0.35%
CGON - SYRE
52%
Loosely correlated
-0.94%
XNCR - SYRE
52%
Loosely correlated
-2.58%
More